Synthetic bacteriophages represent a significant advancement in microbial diagnostics, offering rapid, specific, and scalable detection of bacterial pathogens. Engineered to target distinct bacterial strains, these phages incorporate biosensing mechanisms that produce real-time signals, fluorescent, colorimetric, or electrochemical, enabling immediate and accurate identification. This approach overcomes limitations of traditional culture-based assays and high-cost molecular techniques. In clinical diagnostics, synthetic phages enable early detection of infections, including those caused by antibiotic-resistant strains, thereby improving treatment outcomes and reducing diagnostic delays. In food safety, they facilitate precise detection of pathogens such as Salmonella and Escherichia coli, minimizing contamination risks. Environmental applications include monitoring bacterial loads in water, soil, and industrial systems, supporting public health surveillance and ecosystem protection. Recent advances in synthetic biology, nanotechnology, and machine learning have enhanced the sensitivity and portability of phage-based diagnostics. Integration with lab-on-a-chip and biosensor platforms allows real-time, point-of-care testing, particularly in resource-limited settings. Additionally, their role in antimicrobial resistance (AMR) surveillance provides a proactive tool for monitoring emerging threats. Overall, synthetic phages offer a transformative alternative to conventional diagnostics, combining speed, specificity, and adaptability. Their continued development is expected to drive innovation in microbial detection, disease prevention, and global biosecurity.